LINC01522

Across TCGA pan-cancer cohorts, LINC01522 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated LINC01522 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher LINC01522 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01522 expression acts as an unfavorable survival marker, although some lineages such as LGG and CESC show a favorable association.

KIRC, COAD, and LGG are the cancer types where LINC01522 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Quartile	All	0.527	0.735	<.001	84	view →
COAD	OS	Tertile	II,III,IV	0.458	0.713	.007	43	view →
LGG	DFS	Median	All	0.796	0.678	<.001	38	view →
UCEC	DFS	Median	All	0.786	0.877	<.001	38	view →
KIRP	DFS	Median	IV	0.036	0.596	<.001	36	view →
LUAD	OS	Tertile	IV	0.441	0.773	.038	24	view →
CESC	OS	Tertile	IV	0.622	0.118	.032	12	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	9	view →
MESO	DFS	Quartile	IV	0.842	0.424	.011	9	view →
READ	DFS	Tertile	IV	0.179	0.936	.010	9	view →
ESCA	OS	Median	III,IV	0.538	0.310	.024	7	view →
LIHC	DFS	Tertile	III,IV	0.630	0.285	.049	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

LINC01522–KIRC (OS)

Open the KIRC breakdown →